To investigate the effect of both CDKN1A in PC9 and TIMP3 in A549 on cell proliferation in ALKBH5-deficient lung cancer cell lines, we confirmed the reduced expression using siRNA (Fig. 7C, D, S7A, B). Here, CDKN1A is linked to lung carcinoma.